Corporate Details

Sosei Group Corporation

Established

June 22, 1990

Capital

40,219 million yen (as of 31 December 2020)

Scope of Business

Planning strategy for the entire Group and managing subsidiary companies

Representative Executive Officer, Chairman, President and Chief Executive Officer

Shinichi Tamura

Securities Code

4565-JP

Accounting Period

12 months ended 31 December

Number of Employees

190 (consolidated figure, as of end of December 2020)

Corporate Headquarters

PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan
Tel: +81-(0)3-5210-3290 (general enquiries)
Fax: +81-(0)3-5210-3291

Company Registration Number and Date

0100-01-021288 registered on 22 June 1990

Sosei Group Corporation London Branch

Scope of Business

Corporate representation in the UK

Address

North West House,
119 Marylebone Road,
London, NW1 5PU
United Kingdom
Tel: +44(0)1223 949 100

Company Registration Number and Date

FC024112 registered on 01 April 2002

UK Branch Registration Number and Date

BR006736 registered on 01 April 2002

VAT Number

GB 809812124

Group Companies

Sosei Co. Ltd.

Capital

JPY 90,000,000

Scope of Business

Drug development and sales, business development in Japan

Representative Director

Tadayoshi Yasui

Holding Company Stake

100%

Address

PMO Hanzomon 11F
2-1 Kojimachi, Chiyoda-ku
Tokyo 102-0083 Japan
Tel: +81-(0)3-5210-3290 (general enquiries)
Fax: +81-(0)3-5210-3291

Company Registration Number and Date

0100-01-103556 registered on 02 October 2006

Heptares Therapeutics Ltd.

Capital

JPY 70,025,768

Scope of Business

Drug discovery based on targeting of G protein-coupled receptors

Representative Director

Malcolm Weir

Holding Company Stake

100%

Address

Steinmetz Building, Granta Park
Great Abington,
Cambridge CB21 6GT
United Kingdom
Tel: +44 (0)1223 949 100

Company Registration Number and Date

06267989 registered on 04 June 2007

VAT Number

GB 912562244

EORI Number

GB 912562244000

Data Protection Registration Number and Date

Z1055500 registered on 21 September 2007

Heptares Therapeutics Ireland Limited

Capital

EUR 100

Scope of Business

Corporate representation in the EU

Representative Director

Chris Cargill

Holding Company Stake

100% by Heptares Therapeutics Ltd in UK

Address

c/o Byrne Wallace LLP
88 Harcourt Street,
Dublin 2,
D02 DK18
Ireland

Company Registration Number and Date

656998 registered on 16 September 2019